Azacitidine Plus Nivolumab Following Reduced-intensity Allogeneic PBSC Transplantation for Patients With AML and High-risk Myelodysplasia
Clinical trial NCT04128020 · WITHDRAWN
Trial details
- NCT number
- NCT04128020
- Sponsor
- Sherif Farag
- Status
- WITHDRAWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-10-10
- Primary completion
- 2020-09-28
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.